Raemaekers JM - Search Results

1

[Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].

Raemaekers JM, Snoeijen JJ, Bogman MJ, Rutten E, Strijk SP, Manni JJ. Raemaekers JM, et al. Ned Tijdschr Geneeskd. 1993 Apr 17;137(16):815-20. Ned Tijdschr Geneeskd. 1993. PMID: 8487885 Dutch.

2

Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry.

Brons PP, Raemaekers JM, Bogman MJ, van Erp PE, Boezeman JB, Pennings AH, Wessels HM, Haanen C. Brons PP, et al. Among authors: raemaekers jm. Blood. 1992 Nov 1;80(9):2336-43. Blood. 1992. PMID: 1421404 Free article.

3

[Rational use of antibiotics in the neutropenic patient with fever].

de Pauw BE, Donnelly JP, Raemaekers JM, Hoogkamp-Korstanje JA. de Pauw BE, et al. Among authors: raemaekers jm. Ned Tijdschr Geneeskd. 1995 Aug 26;139(34):1725-9. Ned Tijdschr Geneeskd. 1995. PMID: 7566238 Review. Dutch. No abstract available.

4

Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation.

Meijerink JP, Goverde GJ, Smetsers TF, Raemaekers JM, Bogman MJ, de Witte T, Mensink EJ. Meijerink JP, et al. Among authors: raemaekers jm. Ann Oncol. 1994;5 Suppl 1:43-5. doi: 10.1093/annonc/5.suppl_1.s43. Ann Oncol. 1994. PMID: 8172816

5

The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma. A phase-I study.

Raemaekers JM, van Imhoff GW, Verdonck LF, Hessels JA, Fibbe WE. Raemaekers JM, et al. Ann Hematol. 1993 Oct;67(4):175-81. doi: 10.1007/BF01695864. Ann Hematol. 1993. PMID: 8218538 Clinical Trial.

6

Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction.

Meijerink JP, Smetsers TF, Raemaekers JM, Bogman MJ, De Witte T, Mensink EJ. Meijerink JP, et al. Among authors: raemaekers jm. Br J Haematol. 1993 Jun;84(2):250-6. doi: 10.1111/j.1365-2141.1993.tb03060.x. Br J Haematol. 1993. PMID: 8398826

7

New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation.

Meijerink JP, Raemaekers JM, Mensink EJ. Meijerink JP, et al. Among authors: raemaekers jm. Br J Haematol. 1995 Nov;91(3):630-9. doi: 10.1111/j.1365-2141.1995.tb05359.x. Br J Haematol. 1995. PMID: 8555066

8

[Diagnosis and treatment of low-grade non-Hodgkin lymphoma in 1996].

Mandigers CM, Raemaekers JM, Bogman MJ, de Pauw BE. Mandigers CM, et al. Among authors: raemaekers jm. Ned Tijdschr Geneeskd. 1996 Aug 3;140(31):1587-91. Ned Tijdschr Geneeskd. 1996. PMID: 8768811 Review. Dutch. No abstract available.

9

[Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group].

Raemaekers JM, van 't Veer MB, Bogman MJ. Raemaekers JM, et al. Ned Tijdschr Geneeskd. 1996 Aug 3;140(31):1600-4. Ned Tijdschr Geneeskd. 1996. PMID: 8768814 Clinical Trial. Dutch.

10

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.

Raemaekers J, Burgers M, Henry-Amar M, Pinna A, Mandard A, Monfardini S, Hagenbeek A, Breed W, Carde P, Vovk M, van Hoof A, Thomas J, Noordijk E. Raemaekers J, et al. Ann Oncol. 1997;8 Suppl 1:111-4. Ann Oncol. 1997. PMID: 9187443 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters